222 related articles for article (PubMed ID: 29072681)
1. Demethylzeylasteral inhibits cell proliferation and induces apoptosis through suppressing MCL1 in melanoma cells.
Zhao Y; He J; Li J; Peng X; Wang X; Dong Z; Zhao E; Liu Y; Wu Z; Cui H
Cell Death Dis; 2017 Oct; 8(10):e3133. PubMed ID: 29072681
[TBL] [Abstract][Full Text] [Related]
2. Lycorine hydrochloride inhibits cell proliferation and induces apoptosis through promoting FBXW7-MCL1 axis in gastric cancer.
Li C; Deng C; Pan G; Wang X; Zhang K; Dong Z; Zhao G; Tan M; Hu X; Shi S; Du J; Ji H; Wang X; Yang L; Cui H
J Exp Clin Cancer Res; 2020 Oct; 39(1):230. PubMed ID: 33126914
[TBL] [Abstract][Full Text] [Related]
3. Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanoma.
Tseng HY; Dreyer J; Emran AA; Gunatilake D; Pirozyan M; Cullinane C; Dutton-Regester K; Rizos H; Hayward NK; McArthur G; Hersey P; Tiffen J; Gallagher S
Int J Cancer; 2020 Oct; 147(8):2176-2189. PubMed ID: 32249419
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy.
Santer FR; Erb HH; Oh SJ; Handle F; Feiersinger GE; Luef B; Bu H; Schäfer G; Ploner C; Egger M; Rane JK; Maitland NJ; Klocker H; Eder IE; Culig Z
Oncotarget; 2015 Mar; 6(8):6105-22. PubMed ID: 25749045
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Mcl-1 confers resistance to BRAFV600E inhibitors alone and in combination with MEK1/2 inhibitors in melanoma.
Fofaria NM; Frederick DT; Sullivan RJ; Flaherty KT; Srivastava SK
Oncotarget; 2015 Dec; 6(38):40535-56. PubMed ID: 26497853
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis induced by 9,11‑dehydroergosterol peroxide from Ganoderma Lucidum mycelium in human malignant melanoma cells is Mcl‑1 dependent.
Zheng L; Wong YS; Shao M; Huang S; Wang F; Chen J
Mol Med Rep; 2018 Jul; 18(1):938-944. PubMed ID: 29845223
[TBL] [Abstract][Full Text] [Related]
7. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models.
Kotschy A; Szlavik Z; Murray J; Davidson J; Maragno AL; Le Toumelin-Braizat G; Chanrion M; Kelly GL; Gong JN; Moujalled DM; Bruno A; Csekei M; Paczal A; Szabo ZB; Sipos S; Radics G; Proszenyak A; Balint B; Ondi L; Blasko G; Robertson A; Surgenor A; Dokurno P; Chen I; Matassova N; Smith J; Pedder C; Graham C; Studeny A; Lysiak-Auvity G; Girard AM; Gravé F; Segal D; Riffkin CD; Pomilio G; Galbraith LC; Aubrey BJ; Brennan MS; Herold MJ; Chang C; Guasconi G; Cauquil N; Melchiore F; Guigal-Stephan N; Lockhart B; Colland F; Hickman JA; Roberts AW; Huang DC; Wei AH; Strasser A; Lessene G; Geneste O
Nature; 2016 Oct; 538(7626):477-482. PubMed ID: 27760111
[TBL] [Abstract][Full Text] [Related]
8. Synergistic melanoma cell death mediated by inhibition of both MCL1 and BCL2 in high-risk tumors driven by NF1/PTEN loss.
He S; Zimmerman MW; Layden HM; Berezovskaya A; Etchin J; Martel MW; Thurston G; Jing CB; van Rooijen E; Kaufman CK; Rodig SJ; Zon LI; Patton EE; Mansour MR; Look AT
Oncogene; 2021 Sep; 40(38):5718-5729. PubMed ID: 34331013
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors.
Zhang S; Zhang M; Jing Y; Yin X; Ma P; Zhang Z; Wang X; Di W; Zhuang G
Nat Commun; 2018 Jan; 9(1):215. PubMed ID: 29335437
[TBL] [Abstract][Full Text] [Related]
10. MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells.
Mukherjee N; Skees J; Todd KJ; West DA; Lambert KA; Robinson WA; Amato CM; Couts KL; Van Gulick R; MacBeth M; Nassar K; Tan AC; Zhai Z; Fujita M; Bagby SM; Dart CR; Lambert JR; Norris DA; Shellman YG
Cell Death Dis; 2020 Jun; 11(6):443. PubMed ID: 32513939
[TBL] [Abstract][Full Text] [Related]
11. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis.
Saleem M; Maddodi N; Abu Zaid M; Khan N; bin Hafeez B; Asim M; Suh Y; Yun JM; Setaluri V; Mukhtar H
Clin Cancer Res; 2008 Apr; 14(7):2119-27. PubMed ID: 18381953
[TBL] [Abstract][Full Text] [Related]
12. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
[No Abstract] [Full Text] [Related]
13. Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma.
Klanova M; Andera L; Brazina J; Svadlenka J; Benesova S; Soukup J; Prukova D; Vejmelkova D; Jaksa R; Helman K; Vockova P; Lateckova L; Molinsky J; Maswabi BC; Alam M; Kodet R; Pytlik R; Trneny M; Klener P
Clin Cancer Res; 2016 Mar; 22(5):1138-49. PubMed ID: 26467384
[TBL] [Abstract][Full Text] [Related]
14. Interplay between protein acetylation and ubiquitination controls MCL1 protein stability.
Shimizu K; Gi M; Suzuki S; North BJ; Watahiki A; Fukumoto S; Asara JM; Tokunaga F; Wei W; Inuzuka H
Cell Rep; 2021 Nov; 37(6):109988. PubMed ID: 34758305
[TBL] [Abstract][Full Text] [Related]
15. ApoG2 inhibits the antiapoptotic protein, Mcl‑1, and induces mitochondria‑dependent apoptosis in human colorectal cancer cells.
Li T; Yuan G; Zhang L; Ye L; Li S; Fan Y; Sun J
Mol Med Rep; 2015 Nov; 12(5):6976-84. PubMed ID: 26352605
[TBL] [Abstract][Full Text] [Related]
16. Multiple components of the spliceosome regulate Mcl1 activity in neuroblastoma.
Laetsch TW; Liu X; Vu A; Sliozberg M; Vido M; Elci OU; Goldsmith KC; Hogarty MD
Cell Death Dis; 2014 Feb; 5(2):e1072. PubMed ID: 24556687
[TBL] [Abstract][Full Text] [Related]
17. MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade.
Mukherjee N; Katsnelson E; Brunetti TM; Michel K; Couts KL; Lambert KA; Robinson WA; McCarter MD; Norris DA; Tobin RP; Shellman YG
Cell Death Dis; 2024 Mar; 15(3):198. PubMed ID: 38459020
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of demethylzeylasteral, a triterpenoid of the genus Tripterygium wilfordii.
Sun X; Shen B; Yu H; Wu W; Sheng R; Fang Y; Guo R
Fitoterapia; 2022 Nov; 163():105333. PubMed ID: 36244595
[TBL] [Abstract][Full Text] [Related]
19. A phenylphthalimide derivative, TC11, induces apoptosis by degrading MCL1 in multiple myeloma cells.
Ichikawa D; Nakamura M; Murota W; Osawa S; Matsushita M; Yanagawa H; Hattori Y
Biochem Biophys Res Commun; 2020 Jan; 521(1):252-258. PubMed ID: 31653349
[TBL] [Abstract][Full Text] [Related]
20. Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells.
Mukherjee N; Lu Y; Almeida A; Lambert K; Shiau CW; Su JC; Luo Y; Fujita M; Robinson WA; Robinson SE; Norris DA; Shellman YG
Oncotarget; 2017 Jul; 8(29):46801-46817. PubMed ID: 27086916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]